Human-Identical Milk Oligosaccharides in Infant Formula: How Close Are We to Evidence-Based Benefit?
Advances in Nutrition · 2026-04 · 17 (4) · 100612
DOI: 10.1016/j.advnut.2026.100612 ↗Kurz gefasst
Editorial in der Zeitschrift Advances in Nutrition, 2026-04. Verfasst von Yarden Golan. Beteiligte Einrichtung: Division of Nutritional Sciences, Cornell University, Ithaca, NY, United States. Electronic address: yarden.golan@cornell.edu. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Nutritional Sciences, Cornell University, Ithaca, NY, United States. Electronic address: yarden.golan@cornell.edu.
Förderung
- National Institute of Child Health and Human Development
Zitieren
APA
Golan, Y. (2026). Human-Identical Milk Oligosaccharides in Infant Formula: How Close Are We to Evidence-Based Benefit?. Advances in Nutrition, 17(4), 100612. https://doi.org/10.1016/j.advnut.2026.100612
Vancouver
Golan Y. Human-Identical Milk Oligosaccharides in Infant Formula: How Close Are We to Evidence-Based Benefit?. Advances in Nutrition. 2026;17(4):100612. doi:10.1016/j.advnut.2026.100612
BibTeX
@article{Golan2026,
author = {Golan, Yarden},
title = {Human-Identical Milk Oligosaccharides in Infant Formula: How Close Are We to Evidence-Based Benefit?},
journal = {Advances in Nutrition},
year = {2026},
volume = {17},
number = {4},
pages = {100612},
doi = {10.1016/j.advnut.2026.100612}
}
EUVIMED